Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,199
datasets available to search
ShareScore release 0.9.0
Dataset results
1,199 results for “carboplatin”
Supplementary dataset for 'A randomised phase III trial of carboplatin compared with docetaxel in BRCA1/2 mutated and pre-specified triple negative breast cancer "BRCAness" subgroups: the TNT Trial'
<p>This dataset corresponds to the PAM50 gene expression profiling of primary tumour samples that were collected as part of the TNT clinical trial (ISRCTN97330959, NCT00532727, CRUK/07/012). NanoString® platform nCounter analysis was performed on the RNA extracts at the Institute of Cancer Research and Royal Marsden Hospital. The manuscript describing the trial outcome is currently under review in Nature Medicine.</p>
A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Can
ClinicalTrials.gov study NCT02163694. IPD Sharing: YES. Countries: 37. Publications: 5.
Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).
ClinicalTrials.gov study NCT04472429. IPD Sharing: YES. Countries: 13. Publications: 2.
Trial of Combination ABI-007, Carboplatin, and Gemcitabine for First Line Treatment of Advanced Urothelial Cancer
ClinicalTrials.gov study NCT00995488. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer
ClinicalTrials.gov study NCT04256421. IPD Sharing: YES. Countries: 23. Publications: 1.
Vorinostat, Carboplatin and Gemcitabine in Women With Recurrent, Platinum-Sensitive Ovarian Cancer
ClinicalTrials.gov study NCT00910000. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00323869. IPD Sharing: NO. Countries: 1. Publications: 1.
Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negati
ClinicalTrials.gov study NCT01881230. IPD Sharing: Not stated. Countries: 12. Publications: 2.
A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer
ClinicalTrials.gov study NCT00937560. IPD Sharing: Not stated. Countries: 9. Publications: 1.
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-
ClinicalTrials.gov study NCT02366143. IPD Sharing: Not stated. Countries: 26. Publications: 9.
A Safety and Efficacy Study of Carboplatin, Paclitaxel, Bevacizumab and CA4P in Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00653939. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC)
ClinicalTrials.gov study NCT02978716. IPD Sharing: NO. Countries: 8. Publications: 2.
Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovari
ClinicalTrials.gov study NCT01081262. IPD Sharing: Not stated. Countries: 1. Publications: 1.
LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer
ClinicalTrials.gov study NCT01015118. IPD Sharing: Not stated. Countries: 22. Publications: 2.
Ph I/II Nab-Paclitaxel & Carboplatin w/Concurrent Radiation Therapy for Unresectable Stg III NSCLC
ClinicalTrials.gov study NCT00544648. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Carboplatin Plus Etoposide With or Without Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
ClinicalTrials.gov study NCT02763579. IPD Sharing: Not stated. Countries: 21. Publications: 6.
Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL
ClinicalTrials.gov study NCT03016871. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinoma
ClinicalTrials.gov study NCT00231868. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
ClinicalTrials.gov study NCT00112489. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Radiation Therapy Combined With Paclitaxel and Carboplatin in Treating Patients With Stage III Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00023673. IPD Sharing: Not stated. Countries: 2. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.